A 1999 clinical study that Merck & Co Inc (MRK.N) said was done to test side effects of its now-withdrawn painkiller Vioxx was done primarily to support a marketing campaign before its launch, according to researchers.
The real aim of the study, called ADVANTAGE, was to promote prescription of the new medicine when it became available -- a so-called "seeding" project -- U.S. researchers said on Tuesday.
"Documentary evidence shows that ADVANTAGE is an example of marketing framed as science," they wrote in the journal Annals of Internal Medicine.
Kevin Hill, a psychiatrist at McLean Hospital in Belmont, Mass., and colleagues said the findings showed how studies masquerading as clinical science could be used to bolster marketing plans.
A US jury has ordered drugmaker Johnson & Johnson to pay $417m to a woman who...
Scrapping Obamacare’s cost-sharing subsidies would increase premiums on the most popular plans by 20 percent next...
Snack company KIND dumped 45,485 pounds of sugar in Times Square Tuesday to spark conversation about...
President Donald Trump has threatened to blow up Obamacare. But his own administration is separately dangling...
